Close Menu

NEW YORK – The last few quarters haven't been easy for Enzo Biochem — the company's year-over-year revenues fell 7 percent in its fiscal fourth quarter (ended July 31), sank 14 percent in Q3, and barely ticked up 1 percent in Q2. The COVID-19 pandemic seemed to hit the diagnostics company hard, adversely affecting its clinical services revenues, diagnostic testing volumes, and product revenues.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.